HCPCS J2427

Injection, paliperidone palmitate extended release (invega hafyera, or invega trinza), 1 mg

HCPCS Information

HCPCS Code: J2427
The Healthcare Common Procedure Coding System (HCPCS) is a set of unique alphanumeric codes used to report medical procedures and services to healthcare programs like Medicare and Medicaid. HCPCS codes are used in conjunction with NDC codes for billing and medical documentation puporses. For instance, HCPCS J2427 identifies the type of service or supply used while any of the 6 NDC codes below could be used to specify the exact drug used.
Short Description
Inj, invega hafyera/trinza
Long Description
Injection, paliperidone palmitate extended release (invega hafyera, or invega trinza), 1 mg
Pricing Indicator
Drugs
Multiple Pricing Indicator
Not applicable as HCPCS priced under one methodology
Coverage Description
Carrier judgment
BETOS Type of Service
Other drugs
Medicare Payment Limit
$12.96
Medicare Co-Insurance Percentage
20.000%
HCPCS Classification
List of HCPCS codes for: Drugs Administered Other Than Oral Method, Chemotherapy Drugs (J-codes)

HCPCS Crossover to NDC Codes

The NDC codes below allow precise billing based on the specific manufacturer and medication used:

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
50458-606Invega Trinza Paliperidone PalmitateInjection, Suspension, Extended ReleaseIntramuscularJanssen Pharmaceuticals, IncACTIVE
50458-607Invega Trinza Paliperidone PalmitateInjection, Suspension, Extended ReleaseIntramuscularJanssen Pharmaceuticals, IncACTIVE
50458-608Invega Trinza Paliperidone PalmitateInjection, Suspension, Extended ReleaseIntramuscularJanssen Pharmaceuticals, IncACTIVE
50458-609Invega Trinza Paliperidone PalmitateInjection, Suspension, Extended ReleaseIntramuscularJanssen Pharmaceuticals, IncACTIVE
50458-611Invega Hafyera Paliperidone PalmitateInjection, Suspension, Extended ReleaseIntramuscularJanssen Pharmaceuticals, IncACTIVE
50458-612Invega Hafyera Paliperidone PalmitateInjection, Suspension, Extended ReleaseIntramuscularJanssen Pharmaceuticals, IncACTIVE